Influenza and HIV: Lessons from the 2009 H1N1 influenza pandemic

被引：33
作者：
Sheth A.N. [1 ,3 ]
Patel P. [2 ]
Peters P.J. [2 ]
机构：
[1] Department of Medicine, Emory University School of Medicine, Atlanta, GA
[2] Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA
[3] Atlanta, GA 30303
来源：
Current HIV/AIDS Reports | 2011年 / 8卷 / 3期
关键词：
Complications of HIV infection and treatment; Epidemiology; H1N1; Human immunodeficiency virus; Influenza; Pandemic;
D O I：
10.1007/s11904-011-0086-4
中图分类号：
学科分类号：
摘要：
Influenza is a common respiratory disease in adults, including those infected with HIV. In the spring of 2009, a pandemic influenza A (H1N1) virus (pH1N1) emerged. In this article, we review the existing literature regarding pH1N1 virus infection in HIV-infected adults, which suggests that susceptibility to pH1N1 virus infection and severity of influenza illness are likely not increased in HIV-infected adults without advanced immunosuppression or comorbid conditions. The risk of influenza-related complications, however, may be increased in those with advanced immunosuppression or high-risk comorbid conditions. Prevention and treatment of high-risk comorbid conditions and annual influenza vaccination should continue to be part of HIV clinical care to help prevent influenza illness and complications. Additional information about pH1N1 vaccine immunogenicity and efficacy in HIV-infected patients would be useful to guide strategies to prevent influenza virus infection in this population. © Springer Science+Business Media, LLC 2011.
引用
收藏
页码：181 / 191
页数：10
相关论文
共 91 条
[1]  
Beck J.M., Rosen M.J., Peavy H.H., Pulmonary complications of HIV infection, Am J Respir Crit Care Med., 164, 11, pp. 2120-2126, (2001)
[2]  
Dawood F.S., Jain S., Finelli L., Et al., Emergence of a novel swine-origin influenza A (H1N1) virus in humans, New Engl J Med., 360, 25, pp. 2605-2615, (2009)
[3]  
Bishop J.F., Murnane M.P., Owen R., Australia's winter with the 2009 pandemic influenza A (H1N1) virus, New Engl J Med., 361, 27, pp. 2591-2594, (2009)
[4]  
Update: Influenza Activity-United States, 2009-10 Season, 59, 29, pp. 901-908, (2010)
[5]  
Klein M.B., Lu Y., DelBalso L., Cote S., Boivin G., Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination, Clinical Infectious Diseases, 45, 2, pp. 234-240, (2007)
[6]  
Althoff K., Gange S., Sharp G., Et al., Elevated 2009 H1N1 antibody titers in HIV-infected and uninfected women in the US: A sero-study, 17th Conference on Retroviruses and Opportunistic Infections, 2010, (2010)
[7]  
Kok J., Tudo K., Blyth C.C., Foo H., Hueston L., Dwyer D.E., Pandemic (H1N1) 2009 influenza virus seroconversion rates in HIV-infected individuals, J Acquir Immune Defic Syndr, 56, 2, pp. 91-94, (2011)
[8]  
Gilbert G.L., Cretikos M.A., Hueston L., Doukas G., O'Toole B., Dwyer D.E., Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter, PLoS One, 5, 9, (2010)
[9]  
Kajaste-Rudnitski A., Galli L., Nozza S., Et al., Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals, AIDS, 25, 2, pp. 177-183, (2011)
[10]  
Manuel O., Pascual M., Hoschler K., Et al., Humoral response to the influenza A H1N1/09 Monovalent AS03-Adjuvanted vaccine in immunocompromised patients, Clin Infect Dis., 52, 2, pp. 248-256, (2011)
12345678910